Juvenile myoclonic epilepsy

disorder

SNOMED 6204001CUI C0270853

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Treatments & Interventions

Levetiracetam

substance

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

EEG: spike and multispike waves, 3-4 hz

Very frequent (80-99%)HP:0002392

Generalised-onset seizure

Very frequent (80-99%)HP:0002197

Morning myoclonic jerks

Very frequent (80-99%)HP:0007000

Abnormal mouth

Frequent (30-79%)HP:0000153

Eye movement issue

Frequent (30-79%)HP:0000496

Generalized tonic-clonic seizure (without specification of onset)

Frequent (30-79%)HP:0002069

Myoclonic seizure

Frequent (30-79%)HP:0032794

Febrile seizure (within the age range of 3 months to 6 years)

Occasional (5-29%)HP:0002373

Generalized non-motor (absence) seizure

Occasional (5-29%)HP:0002121

Photically induced tonic-clonic seizure

Occasional (5-29%)HP:0007207

Aggression

Very rare (1-4%)HP:0000718

EEG with generalized polyspikes

HP:0012001

Mental-retardation

Excluded (<1%)HP:0001249

Prolonged seizure

HP:0002133

Related Conditions

Idiopathic generalized epilepsy(parent)

Quick Facts

SNOMED CT: 6204001
UMLS CUI: C0270853
Fully Specified Name: Juvenile myoclonic epilepsy (disorder)
Specialists: 0
Diagnostic Biomarkers: 0
HPO Phenotypes: 14
Known Treatments: 1

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.